AMRX
What one share of Amneal Pharmaceuticals holds
Pharmaceutical Preparations
Amneal Pharmaceuticals, Inc. (the “Company”, “we,” “us,” or “our”) is a diversified, global biopharmaceutical company that develops, manufactures, markets, and distributes a diverse portfolio of essential medicines. Our Affordable Medicines segment includes retail generics, injectables, and biosimilars.
Amneal Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $9.52 |
|---|---|
| Profit | $0.48 |
| Capex (buildings and equipment) | $0.22 |
| Free cash flow | $0.39 |
| Cash and investments | $0.40 |
| Debt | $8.05 |
| Book value | $0.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $13.07 | −$0.16 | $0.65 | $1.31 | — | $3.97 |
| 2019 | $12.31 | −$2.74 | $0.36 | −$0.34 | — | $1.76 |
| 2020 | $13.38 | $0.61 | $0.38 | $2.17 | — | $2.06 |
| 2021 | $13.79 | $0.07 | $0.31 | $1.28 | — | $2.42 |
| 2022 | $14.66 | −$0.86 | $0.31 | $0.12 | — | $1.98 |
| 2023 | $13.59 | −$0.48 | $0.25 | $1.72 | — | $0.06 |
| 2024 | $9.04 | −$0.38 | $0.17 | $0.79 | — | −$0.35 |
| 2025 | $9.29 | $0.22 | $0.22 | $0.83 | — | −$0.23 |